戻る
Lineage Cell Therapeutics Inc (LCTX)価格
LCTX 株価推移チャート
LCTX 収入
Lineage Cell Therapeutics Inc
$1.7
2.71%
$0.04
終値： Jan 16, 16:00:00 GMT-5
$1.72
1.17%
$0.02
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$1.65
始値
$1.66
当日レンジ
$1.62 - $1.73
52週レンジ
$0.37 - $2.09
取引高
1.4M
平均取引高
1.6M
1株当たり利益(TTM)
-0.18
配当利回り
--
時価総額
$396.1M
LCTXとは何ですか？
Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company is headquartered in Carlsbad, California and currently employs 70 full-time employees. The Company’s programs are based on its cell-based technology platform and associated development and manufacturing capabilities. From this platform, it designs, develops, manufactures, and tests specialized human cells with anatomical and physiological functions. Its neuroscience focused pipeline includes OpRegen, a retinal pigment epithelial cell therapy in phase II a development, for the treatment of geographic atrophy secondary to age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy in phase I/II a development for the treatment of spinal cord injuries; ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; PNC1, a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage; and RND1.